Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.83 |
| ▸ | BLM | P54132 | 1/20 | 0.83 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.83 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | INPPL1 | O15357 | 2/20 | 0.33 |
| ▸ | INPP5A | Q14642 | 2/20 | 0.33 |
| ▸ | BTN3A1 | O00481 | 2/20 | 0.33 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.33 |
| ▸ | INPP5B | P32019 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | ITPR3 | Q14573 | 3/20 | 0.32 |
| ▸ | ITPR2 | Q14571 | 1/20 | 0.32 |
| ▸ | ITPR1 | Q14643 | 1/20 | 0.32 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrophosphoric Acid SCHEMBL28854388 | 1.00 | FDPS (0.83) | FDPSBLMTDP1CA4INPPL1 | |
| Pyrophosphoric Acid SCHEMBL28993320 | 0.96 | FDPS (0.77) | FDPSBLMTDP1CA4INPPL1 | |
| Pyrophosphoric Acid SCHEMBL27924187 | 0.96 | FDPS (0.77) | FDPSBLMTDP1CA4INPPL1 | |
| Pyrophosphoric Acid SCHEMBL8660064 | 0.96 | FDPS (0.77) | FDPSBLMTDP1CA4INPPL1 | |
| Pyrophosphoric Acid SCHEMBL9490968 | 0.96 | FDPS (0.77) | FDPSBLMTDP1CA4INPPL1 | |
| Pyrophosphoric Acid SCHEMBL9493162 | 0.96 | FDPS (0.77) | FDPSBLMTDP1CA4INPPL1 | |
| Pyrophosphoric Acid SCHEMBL18670528 | 0.96 | FDPS (0.91) | FDPSBLMTDP1CA4INPPL1 | |
| Pyrophosphoric Acid SCHEMBL440052 | 0.96 | FDPS (0.91) | FDPSBLMTDP1CA4INPPL1 | |
| Pyrophosphoric Acid SCHEMBL621307 | 0.96 | FDPS (0.91) | FDPSBLMTDP1CA4INPPL1 | |
| Pyrophosphoric Acid SCHEMBL5550825 | 0.96 | FDPS (0.91) | FDPSBLMTDP1CA4INPPL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116081693-A | Method for refining manganese sulfate product by removing impurities from calcium and magnesium | 何长荣 | 2023-05-09 | — | — | CN | claimed |
| US-20120164216-A1 | PHARMACEUTICAL COMPOSITION OF DULOXETINE OR PHARMACEUTICALLY | MATE SANJAY (IN) | 2012-06-28 | — | — | US | claimed |
| WO-2010150219-A1 | PHARMACEUTICAL COMPOSITION OF DULOXETINE OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | WOCKHARDT RESEARCH CENTRE (IN) | 2010-12-29 | — | — | WO | claimed |
| US-7037867-B2 | Artificial bone graft substitute using calcium phosphate compounds and method of manufacturing the same | SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) | 2006-05-02 | — | — | US | claimed |
| US-6699885-B2 | Treating gastrointestinal disorders by administering solid oral dosage form of proton pump inhibitor and buffer; buffer inhibits degradation of the proton pump inhibitor by gastric acid; bioavailability | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2004-03-02 | — | — | US | claimed |
| US-20030193106-A1 | Artificial bone graft substitute using calcium phosphate compounds and method of manufacturing the same | SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) | 2003-10-16 | — | — | US | claimed |
| EP-0333053-B1 | PHOSPHATE-COATED ELECTROLUMINESCENT PHOSPHOR FOR ELECTROLUMINESCENT LAMP AND A PROCESS FOR PRODUCING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-03-03 | — | — | EP | claimed |
| US-4223115-A | ADDITION POLYMERIZABLE SYSTEM CONTAINING REDOX COUPLE CATALYST AND PHOSPHORUS COMPOUND | LORD CORPORATION (US) | 1980-09-16 | — | — | US | claimed |
| US-12376612-B2 | Edible concentrate comprising microfibrillated cellulose | CONOPCO INC. (US) | 2025-08-05 | — | — | US | disclosed |
| CN-116081693-B | Method for refining manganese sulfate product by removing impurities from calcium and magnesium | 何长荣 | 2024-11-22 | — | — | CN | disclosed |
| US-12042302-B2 | Enhanced ingestible event indicators and methods for making and using the same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2024-07-23 | — | — | US | disclosed |
| CN-116768175-A | Preparation method and application of amorphous calcium magnesium phosphate with high stability and bioactivity | 常州市第二人民医院 | 2023-09-19 | — | — | CN | disclosed |
| CN-116081693-A | Method for refining manganese sulfate product by removing impurities from calcium and magnesium | 何长荣 | 2023-05-09 | — | — | CN | disclosed |
| CN-115970062-A | Bone cement-based drug sustained-release carrier and preparation method thereof | 泽田(山东)药业有限公司 | 2023-04-18 | — | — | CN | disclosed |
| WO-2011121496-A1 | COMPOSITION COMPRISING INSULIN AND HERBAL OIL FOR TRANSDERMAL OR TRANSMUCOSAL ADMINISTRATION | WOCKHARDT LIMITED (IN) | 2011-10-06 | — | — | WO | disclosed |
| WO-2010150219-A1 | PHARMACEUTICAL COMPOSITION OF DULOXETINE OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | WOCKHARDT RESEARCH CENTRE (IN) | 2010-12-29 | — | — | WO | disclosed |
| US-7037867-B2 | Artificial bone graft substitute using calcium phosphate compounds and method of manufacturing the same | SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) | 2006-05-02 | — | — | US | disclosed |
| US-20030193106-A1 | Artificial bone graft substitute using calcium phosphate compounds and method of manufacturing the same | SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) | 2003-10-16 | — | — | US | disclosed |
| EP-0333053-B1 | PHOSPHATE-COATED ELECTROLUMINESCENT PHOSPHOR FOR ELECTROLUMINESCENT LAMP AND A PROCESS FOR PRODUCING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-03-03 | — | — | EP | disclosed |
| EP-0333053-A2 | Phosphate-coated electroluminescent phosphor for electroluminescent lamp and a process for producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1989-09-20 | — | — | EP | disclosed |